Vivani Medical (VANI) Net Cash Flow (2014 - 2026)
Vivani Medical (VANI) posted quarterly Net Cash Flow of $3.5 million for Q1 2026, up 165.85% year-over-year from $1.3 million in Q1 2025, and down 74.15% quarter-over-quarter from $13.6 million in Q4 2025.
Vivani Medical (VANI) Net Cash Flow (2014 - 2026) Analysis & Trends
Vivani Medical's Net Cash Flow history runs 13 years deep, the most recent figure standing at $3.5 million for Q1 2026.
- In Q1 2026, Net Cash Flow rose 165.85% year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $6.6 million (up 139.91% YoY), while the FY2025 annual figure was -$2.2 million, up 3.02% from the prior year.
- Net Cash Flow for Q1 2026 stood at $3.5 million, down from $13.6 million in the prior quarter.
- The five-year high for Net Cash Flow was $48.2 million in Q3 2022, with the low at -$7.7 million in Q3 2023.
- The 5-year median for Net Cash Flow is -$4.2 million (2025), against an average of $1.1 million.
- The sharpest annual moves came in 2022 and 2025: Net Cash Flow plunged 623.35% in 2022, then jumped 1162.34% in 2025.
- Vivani Medical's Net Cash Flow stood at -$5.2 million in 2022, then gained by 19.89% to -$4.2 million in 2023, then surged by 69.53% to -$1.3 million in 2024, then surged by 1162.34% to $13.6 million in 2025, then sank by 74.15% to $3.5 million in 2026.
- Business Quant data shows VANI's Net Cash Flow at $3.5 million in Q1 2026, $13.6 million in Q4 2025, and -$4.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | -301,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -301,000.00 |
| Jun 30, 2026 | -301,000.00 |
| Mar 31, 2026 | 3.52 Mn |
| Mar 31, 2026 | 3.52 Mn |
| Dec 31, 2025 | 13.60 Mn |
| Dec 31, 2025 | 13.60 Mn |
| Sep 30, 2025 | -4.23 Mn |
| Sep 30, 2025 | -4.23 Mn |
| Jun 30, 2025 | -6.25 Mn |
| Jun 30, 2025 | -6.25 Mn |
| Mar 31, 2025 | -5.34 Mn |
| Mar 31, 2025 | -5.34 Mn |
| Dec 31, 2024 | -1.28 Mn |
| Dec 31, 2024 | -1.28 Mn |
| Sep 30, 2024 | -5.28 Mn |
| Sep 30, 2024 | -5.28 Mn |
| Jun 30, 2024 | -4.73 Mn |
| Jun 30, 2024 | -4.73 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Mar 31, 2024 | 9.00 Mn |